Alositol


Combined with:

Lasix

Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Hepatitis C 29.7%
Hypertension 11.3%
Hyperuricaemia 11.3%
Adverse Event 5.9%
Prophylaxis 5.1%
Drug Use For Unknown Indication 3.9%
Nasopharyngitis 3.9%
Atrial Fibrillation 3.5%
Gastritis 3.5%
Hyperlipidaemia 2.7%
Cardiac Failure 2.3%
Pyrexia 2.3%
Thrombosis Prophylaxis 2.3%
Chronic Obstructive Pulmonary Disease 2.0%
Gout 2.0%
Hepatitis C 2.0%
Adverse Reaction 1.6%
Anaemia 1.6%
Insomnia 1.6%
Iron Overload 1.6%
Stevens-johnson Syndrome 17.2%
Rhabdomyolysis 12.1%
Erythema Multiforme 10.3%
Renal Failure Acute 10.3%
Haemoglobin Decreased 6.9%
Hepatic Function Abnormal 5.2%
Hyperuricaemia 3.4%
Neutrophil Count Decreased 3.4%
Respiratory Failure 3.4%
Sinus Arrest 3.4%
Skin Exfoliation 3.4%
Thrombocytopenia 3.4%
White Blood Cell Count Decreased 3.4%
White Blood Cell Count Increased 3.4%
Blood Amylase Increased 1.7%
Cardio-respiratory Arrest 1.7%
Cataract 1.7%
Dermatitis Exfoliative 1.7%
Drug Eruption 1.7%
Hepatitis Acute 1.7%
Concomitant
Hypertension 13.9%
Prophylaxis 13.8%
Chronic Hepatitis C 10.6%
Cardiac Failure 7.6%
Hyperuricaemia 6.8%
Drug Use For Unknown Indication 6.1%
Product Used For Unknown Indication 6.0%
Rheumatoid Arthritis 3.9%
Diabetes Mellitus 3.9%
Hepatitis C 3.7%
Hiv Infection 3.4%
Multiple Myeloma 2.6%
Atrial Fibrillation 2.5%
Insomnia 2.4%
Acute Lymphocytic Leukaemia 2.3%
Gastritis 2.3%
Constipation 2.1%
Neoplasm Malignant 2.1%
Angina Pectoris 2.1%
Chronic Myeloid Leukaemia 2.1%
White Blood Cell Count Decreased 12.8%
Renal Impairment 11.1%
Rash 8.4%
Cardiac Failure 7.7%
Pneumonia 5.4%
Renal Disorder 5.4%
Platelet Count Decreased 5.0%
White Blood Cell Count Increased 5.0%
Interstitial Lung Disease 3.7%
Pyrexia 3.7%
Sepsis 3.7%
Malaise 3.4%
Renal Failure 3.4%
Retinal Haemorrhage 3.4%
Vomiting 3.4%
Hepatic Function Abnormal 3.0%
Hyperuricaemia 3.0%
Restrictive Cardiomyopathy 3.0%
Thrombocytopenia 3.0%
Anaemia 2.7%

Drug Data